1. Silencing of ZFP36L2 increases sensitivity to temozolomide through G2/M cell cycle arrest and BAX mediated apoptosis in GBM cells
   Mohd Firdaus Che Mat et al, 2021, Molecular Biology Reports CrossRef
2. Glioblastoma-specific anticancer activity of newly synthetized 3,5-disubstituted isoxazole and 1,4-disubstituted triazole-linked tyrosol conjugates
   Imen Aissa et al, 2021, Bioorganic Chemistry CrossRef
3. The Use of Ribavirin as an Anticancer Therapeutic: Will It Go Viral?
   Joshua Casaos et al, 2019, Molecular Cancer Therapeutics CrossRef
4. Glioblastoma-synthesized G-CSF and GM-CSF contribute to growth and immunosuppression: Potential therapeutic benefit from dapsone, fenofibrate, and ribavirin
   Richard E Kast et al, 2017, Tumor Biology CrossRef
5. Autophagy suppression sensitizes glioma cells to IMP dehydrogenase inhibition-induced apoptotic death
   Andjelka M. Isakovic et al, 2017, Experimental Cell Research CrossRef
6. Combination Therapy of Temozolomide, Ribavirin and Interferon-Beta for Glioblastoma In Vivo
   Genki Yazawa et al, 2023, Journal of Nihon University Medical Association CrossRef
7. Use of an anti-viral drug, Ribavirin, as an anti-glioblastoma therapeutic
   F Volpin et al, 2017, Oncogene CrossRef
8. The dark side of mRNA translation and the translation machinery in glioblastoma
   Angélica Montiel-Dávalos et al, 2023, Frontiers in Cell and Developmental Biology CrossRef
9. Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemia
   Karen A. Urtishak et al, 2019, Oncogene CrossRef
10. Ribavirin as a potential therapeutic for atypical teratoid/rhabdoid tumors
    Joshua Casaos et al, 2018, Oncotarget CrossRef
11. Design, synthesis, structural characterization and in vitro evaluation of new 1,4-disubstituted-1,2,3-triazole derivatives against glioblastoma cells
    Veronica D. da Silva et al, 2019, Bioorganic Chemistry CrossRef